Drugs in MeSH Category Reverse Transcriptase Inhibitors
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | FOSCARNET SODIUM | foscarnet sodium | INJECTABLE;INJECTION | 212483-001 | Jan 29, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Amneal | FOSCARNET SODIUM | foscarnet sodium | INJECTABLE;INJECTION | 216602-001 | Mar 1, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Viiv Hlthcare | RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705-001 | Apr 4, 1997 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Natco | LAMIVUDINE | lamivudine | TABLET;ORAL | 204528-001 | Mar 4, 2016 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Lupin Ltd | LAMIVUDINE | lamivudine | TABLET;ORAL | 205217-001 | Dec 18, 2014 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Hetero Labs Ltd V | LAMIVUDINE | lamivudine | TABLET;ORAL | 203277-001 | Jan 6, 2014 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Liaoning Chengda | ZIDOVUDINE | zidovudine | INJECTABLE;INJECTION | 204538-001 | Nov 26, 2013 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
